The Brain Tumor Center's multidisciplinary team of neuro-oncologists and neurosurgeons has expertise in diagnosing and treating a wide variety of conditions and it is the patients who benefit from their extensive scientific knowledge.
More than 400 patients per year undergo surgery for brain tumors at Columbia University Medical Center, making it one of the busiest brain tumor centers in the United States. Our multidisciplinary team of neuro-oncologists and neurosurgeons has expertise in diagnosing and treating a wide variety of conditions, including gliomas, acoustic neuromas/schwannomas, meningiomas, colloid cysts, pituitary tumors, pineal tumors, skull base tumors, and pediatric tumors. The broad spectrum of specialized expertise found in the Brain Tumor Center means that patients benefit from the state-of-the-art of scientific knowledge about their particular conditions.
Minimally invasive treatment approaches typically reduce risk in brain tumor surgery. Advanced techniques such as stereotaxis, neuroendoscopy, awake brain mapping, and electrophysiological mapping can maximize tumor removal while minimizing risk. In addition, we utilize novel treatment approaches developed in a nationally acclaimed neuro-oncology research program. Patients also benefit from ongoing research in Department labs that investigate the effectiveness of innovative treatments.
The Columbia Brain Tumor Center is co-directed by Dr. Jeffrey Bruce of Neurological Surgery and Dr. Andrew B. Lassman, Chief of Neuro-oncology at New York-Presbyterian Hospital and Director of Columbia Neurology’s Neuro-Oncology Division.